cirm.ca.gov

Clinical Trial (CLIN2) Awards

CLIN2 applications are now open. Applications are due by October 31, 2025, at 2 PM (PDT). Applications for CLIN2 funding will be accepted four times a year, approximately on a quarterly basis. In 2026 ...
cirm.ca.gov

La familia de genes del retinoblastoma (RB) en la reprogramación celular

Un aspecto importante de la medicina regenerativa es la capacidad de introducir células madre funcionales en los pacientes para restaurar la función del tejido. Este tipo de enfoque terapéutico no se ...
cirm.ca.gov

Researcher Resources

CIRM provides funding across all stages of research, from basic science to translational studies and clinical trials. This support drives best-in-class research aimed at developing innovative ...
cirm.ca.gov

Stem Cell Tourism

Many stem cell clinics, both in the United States and in other countries, advertise cures for a price. Understand the concerns over stem cell tourism and what CIRM is doing to bring real cures to ...
cirm.ca.gov

Alpha Clinics Network

The Alpha Clinics Network is funded and supported by the California Institute for Regenerative Medicine (CIRM). The Network features nine world-class medical centers throughout California with a ...
cirm.ca.gov

CIRM approves $73 million in awards for discovery research

South San Francisco, CA, September 25, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million across 23 grants to support discovery research ...
cirm.ca.gov

CIRM awards $4.7 million for vision loss gene therapy

South San Francisco, CA, May 29, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $4.7 million to ...
cirm.ca.gov

Stem Cell and Genetic Research

When most people think about about stem cells treating disease they think of a stem cell transplant. In a stem cell transplant, stem cells are first specialized into the necessary adult cell type.
cirm.ca.gov

CIRM awards $8 million to advance vision loss gene therapy to clinical trials

South San Francisco, CA, April 24, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved awarding ...
cirm.ca.gov

CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...
cirm.ca.gov

Les souris immunodéficientes sont plus adaptées à la modélisation de la transfusion de composants sanguins humains que les souris sauvages.

Les modèles animaux sont essentiels à l’étude de la transfusion et au développement de nouveaux produits sanguins. La récupération post-transfusionnelle des composants sanguins humains peut être ...
cirm.ca.gov

Managing Your Grant

The following information will help you comply with CIRM regulations and find information about our forms and policies. If you have questions that aren’t addressed on this page contact your Grants ...